Thomas Appio - Mar 3, 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role: CEO, Pharma Business
Signature: /s/ Debra E. Levin, attorney-in-fact for Thomas Appio
Stock symbol: BHC
Transactions as of: Mar 3, 2022
Transactions value $: -$131,366
Form type: 4
Date filed: 3/7/2022, 04:30 PM
Previous filing: Mar 4, 2022
Next filing: May 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHC	Common Shares, No Par Value	Tax liability	-$131K	-5.56K	-1.16%	$23.61	475K	Mar 3, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Remarks:

Due to an inadvertent administrative error, the reporting person previously filed a Form 4 on March 2, 2022 reporting the vesting of performance-based Restricted Share Units ("PSUs") on February 27, 2022. The Issuer's Talent and Compensation Committee of the Board certified the performance goals applicable to these PSUs on February 14, 2022, which was the correct date on which these PSUs performance-vested.